ArticleScientific reports2018

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.

Evan F Garner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.